47 related articles for article (PubMed ID: 3033094)
1. Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.
Natuk RJ; Cooper D; Guo M; Calderon P; Wright KJ; Nasar F; Witko S; Pawlyk D; Lee M; DeStefano J; Tummolo D; Abramovitz AS; Gangolli S; Kalyan N; Clarke DK; Hendry RM; Eldridge JH; Udem SA; Kowalski J
J Virol; 2006 May; 80(9):4447-57. PubMed ID: 16611905
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex viruses: is a vaccine tenable?
Whitley RJ; Roizman B
J Clin Invest; 2002 Jul; 110(2):145-51. PubMed ID: 12122103
[No Abstract] [Full Text] [Related]
3. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.
McClements WL; Armstrong ME; Keys RD; Liu MA
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11414-20. PubMed ID: 8876149
[TBL] [Abstract][Full Text] [Related]
4. NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.
Tine JA; Lanar DE; Smith DM; Wellde BT; Schultheiss P; Ware LA; Kauffman EB; Wirtz RA; De Taisne C; Hui GS; Chang SP; Church P; Hollingdale MR; Kaslow DC; Hoffman S; Guito KP; Ballou WR; Sadoff JC; Paoletti E
Infect Immun; 1996 Sep; 64(9):3833-44. PubMed ID: 8751936
[TBL] [Abstract][Full Text] [Related]
5. Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.
Lanar DE; Tine JA; de Taisne C; Seguin MC; Cox WI; Winslow JP; Ware LA; Kauffman EB; Gordon D; Ballou WR; Paoletti E; Sadoff JC
Infect Immun; 1996 May; 64(5):1666-71. PubMed ID: 8613376
[TBL] [Abstract][Full Text] [Related]
6. Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs.
Heineman TC; Connelly BL; Bourne N; Stanberry LR; Cohen J
J Virol; 1995 Dec; 69(12):8109-13. PubMed ID: 7494331
[TBL] [Abstract][Full Text] [Related]
7. Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.
Guo PX; Goebel S; Davis S; Perkus ME; Languet B; Desmettre P; Allen G; Paoletti E
J Virol; 1989 Oct; 63(10):4189-98. PubMed ID: 2550665
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.
Perkus ME; Limbach K; Paoletti E
J Virol; 1989 Sep; 63(9):3829-36. PubMed ID: 2547999
[TBL] [Abstract][Full Text] [Related]
9. Antigens of infectious laryngotracheitis herpesvirus defined by monoclonal antibodies.
York JJ; Sonza S; Brandon MR; Fahey KJ
Arch Virol; 1990; 115(3-4):147-62. PubMed ID: 2175588
[TBL] [Abstract][Full Text] [Related]
10. Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.
Guo PX; Goebel S; Perkus ME; Taylor J; Norton E; Allen G; Languet B; Desmettre P; Paoletti E
J Virol; 1990 May; 64(5):2399-406. PubMed ID: 2157895
[TBL] [Abstract][Full Text] [Related]
11. Live vaccinia virus recombinants expressing herpes simplex virus genes.
Rooney JF; Wohlenberg CR; Moss B; Notkins AL
Rev Infect Dis; 1991; 13 Suppl 11():S898-903. PubMed ID: 1664124
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
[TBL] [Abstract][Full Text] [Related]
13. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.
Rooney JF; Wohlenberg C; Cremer KJ; Moss B; Notkins AL
J Virol; 1988 May; 62(5):1530-4. PubMed ID: 2833606
[TBL] [Abstract][Full Text] [Related]
14. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D.
Aurelian L; Smith CC; Wachsman M; Paoletti E
Rev Infect Dis; 1991; 13 Suppl 11():S924-34. PubMed ID: 1664130
[TBL] [Abstract][Full Text] [Related]
16. Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.
Wachsman M; Aurelian L; Smith CC; Perkus ME; Paoletti E
J Infect Dis; 1989 Apr; 159(4):625-34. PubMed ID: 2538519
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
